Pages that link to "Q37706134"
Jump to navigation
Jump to search
The following pages link to In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma (Q37706134):
Displaying 12 items.
- Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets (Q33903831) (← links)
- Selection and characterization of a human ovarian cancer cell line resistant to auranofin (Q47135396) (← links)
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics (Q49562067) (← links)
- Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing (Q50005505) (← links)
- Comparative oncology approach to drug repurposing in osteosarcoma. (Q52631134) (← links)
- Developing a genetic signature to predict drug response in ovarian cancer. (Q55028564) (← links)
- Selecting precise reference normal tissue samples for cancer research using a deep learning approach (Q61804793) (← links)
- Leveraging Big Data to Transform Drug Discovery (Q62751529) (← links)
- Harnessing big 'omics' data and AI for drug discovery in hepatocellular carcinoma (Q92407464) (← links)
- Ultrasensitive quantification of tumor mRNAs in extracellular vesicles with an integrated microfluidic digital analysis chip (Q93357115) (← links)
- Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19 (Q95610020) (← links)
- Tales of 1,008 small molecules: phenomic profiling through live-cell imaging in a panel of reporter cell lines (Q98237670) (← links)